Skip to main content
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ARWR ISIN · US04280A1007 LEI · 549300O3CSB8T7OZ3D66 US Manufacturing
Open in API
Filings indexed 1,039 across all filing types
Latest filing 2010-06-01 Regulatory Filings
Country US United States of America
Listing US ARWR

About ARROWHEAD PHARMACEUTICALS, INC.

https://arrowheadpharma.com/

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
POST-EFFECTIVE AMENDMENT NO. 1
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-3 Registration Statement filed with the SEC. It is a regulatory filing related to securities registration under the Securities Act of 1933. The content includes legal and procedural information about the registration of securities, prospectus details, and disclaimers. It does not contain financial statements, earnings data, management discussion, or other report content. It is not an announcement of voting results, nor a report of share transactions or capital changes. It is a formal regulatory filing related to securities registration and amendments thereto.
2010-06-01 English
POST-EFFECTIVE AMENDMENT NO. 2
Regulatory Filings Classification · 95% confidence The document is a Post-Effective Amendment No. 2 to a Form S-1 registration statement filed with the SEC, converting the Form S-1 into a Form S-3 registration statement. It is a registration statement related to the resale of shares by selling stockholders. The document includes a prospectus with risk factors, business description, and offering details. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and offering. The document length is about 15,000 characters, and it is a formal SEC filing for securities registration, not a report or announcement of a report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2010-06-01 English
POST-EFFECTIVE AMENDMENT NO. 1
Capital/Financing Update Classification · 95% confidence The document is titled 'Post-Effective Amendment No. 1' to a Form S-1 registration statement, filed with the SEC. It references the Securities Act of 1933 and SEC registration numbers, and discusses the registration of shares for resale by selling stockholders. The document is a registration statement amendment related to securities offerings, not a financial report, earnings release, or management discussion. It is a formal filing related to capital raising and securities registration. This type of filing corresponds to a Capital/Financing Update (CAP) as it deals with registration and offering of securities for sale. The document length is substantial and contains detailed information about the offering and related legal disclosures, consistent with a capital raising filing rather than a simple announcement or report publication.
2010-06-01 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a change in employment terms for an executive officer, including salary reduction and stock option amendments. This corresponds to announcements about changes in senior management or directors. The relevant filing category for such announcements is 'Board/Management Information' (MANG). The document is not a full report but a regulatory filing announcing management changes, so it fits MANG rather than other categories like 10-K or ER. Confidence is high due to clear identification of management change in the text.
2010-05-28 English
FORM 10-Q
Interim / Quarterly Report Q2 2010
2010-05-13 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 13, 2010, reporting the results of operations and financial condition for the quarter ended March 31, 2010. It includes a press release attached as Exhibit 99.1 announcing quarterly financial results. The document is relatively short (2702 characters) and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly financial results (key highlights only) are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2010-05-13 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.